Yasuhiko Kitasato

Kurume, Japan

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 18 publications

Clinical Outcomes and Acute Exacerbation Incidence in Combined Pulmonary Fibrosis and Emphysema.

Clinical Outcomes and Acute Exacerbation Incidence in Combined Pulmonary Fibrosis and Emphysema.

Journal: Respirology (Carlton, Vic.)

Published: February 04, 2026

Diagnostic utility of high-mobility group box 1 for acute exacerbations of idiopathic pulmonary fibrosis.

Diagnostic utility of high-mobility group box 1 for acute exacerbations of idiopathic pulmonary fibrosis.

Journal: Scientific reports

Published: July 19, 2025

Prognostic impact of muscle mass in idiopathic interstitial pneumonia: analysis of idiopathic pulmonary fibrosis and other idiopathic interstitial pneumonias.

Prognostic impact of muscle mass in idiopathic interstitial pneumonia: analysis of idiopathic pulmonary fibrosis and other idiopathic interstitial pneumonias.

Journal: BMC pulmonary medicine

Published: May 21, 2025

Regional Medical Collaboration May Lead to Early Detection of Interstitial Lung Disease.

Regional Medical Collaboration May Lead to Early Detection of Interstitial Lung Disease.

Journal: Journal of clinical medicine

Published: May 14, 2025

Mortality and exacerbation risk according to GOLD and STAR severity stages of COPD: a 5-year multicenter prospective cohort study.

Mortality and exacerbation risk according to GOLD and STAR severity stages of COPD: a 5-year multicenter prospective cohort study.

Journal: Scientific reports

Published: April 23, 2025

Association Between Single Nucleotide Polymorphisms and Disease Susceptibility, Survival, and Acute Exacerbation in Idiopathic Pulmonary Fibrosis.

Association Between Single Nucleotide Polymorphisms and Disease Susceptibility, Survival, and Acute Exacerbation in Idiopathic Pulmonary Fibrosis.

Journal: Respirology (Carlton, Vic.)

Published: August 28, 2024

Update of prognosis and characteristics of chronic obstructive pulmonary disease in a real-world setting: a 5-year follow-up analysis of a multi-institutional registry.

Update of prognosis and characteristics of chronic obstructive pulmonary disease in a real-world setting: a 5-year follow-up analysis of a multi-institutional registry.

Journal: BMC pulmonary medicine

Published: March 08, 2024

Survival and acute exacerbation for patients with idiopathic pulmonary fibrosis (IPF) or non-IPF idiopathic interstitial pneumonias: 5-year follow-up analysis of a prospective multi-institutional patient registry.

Survival and acute exacerbation for patients with idiopathic pulmonary fibrosis (IPF) or non-IPF idiopathic interstitial pneumonias: 5-year follow-up analysis of a prospective multi-institutional patient registry.

Journal: BMJ open respiratory research

Published: June 01, 2023

Characteristics of tobacco-related lung diseases in Fukuoka Prefecture, Japan: A prospective, multi-institutional, observational study.

Characteristics of tobacco-related lung diseases in Fukuoka Prefecture, Japan: A prospective, multi-institutional, observational study.

Journal: Respiratory investigation

Published: March 06, 2019

A retrospective cohort study of outcome in systemic sclerosis-associated interstitial lung disease.

A retrospective cohort study of outcome in systemic sclerosis-associated interstitial lung disease.

Journal: Respiratory investigation

Published: August 18, 2015

Heterogeneous clinical features in patients with pulmonary fibrosis showing histology of pleuroparenchymal fibroelastosis.

Heterogeneous clinical features in patients with pulmonary fibrosis showing histology of pleuroparenchymal fibroelastosis.

Journal: Respiratory investigation

Published: July 13, 2015

Histological evolution of pleuroparenchymal fibroelastosis.

Histological evolution of pleuroparenchymal fibroelastosis.

Journal: Histopathology

Published: August 12, 2014

Showing 1-12 of 18

Last Updated: 09/26/2026